Does using ethnic specific criteria improve the usefulness of the term metabolic syndrome? controversies and suggestions

被引:0
|
作者
D Banerjee
A Misra
机构
[1] Stanford University School of Medicine,Cardiovascular Disease Division
[2] All India Institute of Medical Sciences,Department of Internal Medicine
[3] Center for Diabetes,undefined
[4] Obesity,undefined
[5] and Cholesterol Disorders (C-DOC),undefined
[6] Diabetes Foundation (India),undefined
[7] SDA,undefined
来源
关键词
metabolic syndrome; insulin resistance; South Asians; diabetes; cardiovascular diseases; ethnicity;
D O I
暂无
中图分类号
学科分类号
摘要
The metabolic syndrome (MetS) is an important tool that identifies populations at increased risk for cardiovascular disease (CVD) and type 2 diabetes, targeting them for preventive measures. The criteria for the identification of the MetS were initially constructed from data in Caucasian populations. Recent research suggests that the current criteria for the MetS may not accurately characterize disease risk in non-Caucasian populations, either over or underestimating the risk in certain ethnic groups. Altering the criteria for each population by making ethnic-specific cutoffs as has been done with waist circumference will help in more accurate characterization. Using different combinations of the MetS criteria for different ethnic groups based CVD risk and factor analysis needs consideration. With better characterizations of patient populations, the ultimate goal would be to make MetS more accurate for predicting CVD risk while retaining the ease of screening afforded by the MetS. The proposed alterations of definition and criteria of the MetS would ensure its continued viability and sustainability.
引用
收藏
页码:1340 / 1349
页数:9
相关论文
共 50 条
  • [31] Investigation of Criteria for Diagnosis of Metabolic Syndrome by Using a Home Body Composition Meter
    Wada, Yuji
    Morita, Hiroyuki
    Kajita, Kazuo
    Ishizuka, Tatsuo
    DIABETES, 2012, 61 : A519 - A519
  • [32] Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?
    Stern, MP
    Williams, K
    González-Villalpando, C
    Hunt, KJ
    Haffner, SM
    DIABETES CARE, 2004, 27 (11) : 2676 - 2681
  • [33] Prevalence of metabolic syndrome and coronary heart disease using NCEP and WHO criteria
    Alexander, CM
    Landsman, PB
    Teutsch, SM
    Haffner, SM
    DIABETES, 2002, 51 : A218 - A218
  • [34] Salsalate Does Not Improve Endothelial Function and Insulin-Stimulated Vasodilation in Patients With Metabolic Syndrome
    Sullivan, Alexander E.
    Shardelow, Emily M.
    Aday, Aaron W.
    Wells, Quinn S.
    Freiberg, Matthew S.
    Beckman, Joshua A.
    CIRCULATION, 2023, 148
  • [35] Does high sensitive CRP improve cardiovascular risk prediction in metabolic syndrome among the aged?
    Salminen, Marika
    Kuoppamaki, Marikka
    Vahlberg, Tero
    Raiha, Ismo
    Irjala, Kerttu
    Kivela, Sirkka-Liisa
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2013, 47 (04) : 210 - 216
  • [36] Does rosuvastatin improve lipid levels in patients with the metabolic syndrome more effectively than atorvastatin?
    Schuster, H
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2006, 3 (02): : 74 - 75
  • [37] Prevalence of metabolic syndrome in Oman using the International Diabetes Federation's Criteria
    Al-Lawati, Jawad A.
    Jousilahti, Pekka
    SAUDI MEDICAL JOURNAL, 2006, 27 (12) : 1925 - 1926
  • [38] Acipimox Does Not Improve Endothelial Function and Insulin-Stimulated Vasodilation in Patients With Metabolic Syndrome
    Sullivan, Alexander
    Shardelow, Emily M.
    Aday, Aaron W.
    Wells, Quinn S.
    Freiberg, Matthew S.
    Beckman, Joshua A.
    CIRCULATION, 2023, 148
  • [39] Does rosuvastatin improve lipid levels in patients with the metabolic syndrome more effectively than atorvastatin?
    Herbert Schuster
    Nature Clinical Practice Cardiovascular Medicine, 2006, 3 : 74 - 75
  • [40] Mineralocorticoid receptor blockade does not improve vascular endothelial function in older adults with metabolic syndrome
    Hwang, Moon-Hyon
    Yoo, Jeung-Ki
    Luttrell, Meredith J.
    Cernosek, Molly M.
    Meade, Thomas H.
    English, Mark W.
    Christou, Demetra D.
    FASEB JOURNAL, 2011, 25